METAGENOMI INC
(NASDAQ: MGX)
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development. The company's metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. Metagenomi forges these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific, and have a decreased risk of the immune response. Metagenomi's goal is to revolutionize gene editing for the benefit of patients around the world. The company was founded in 2018 and is headquartered in Emeryville, California.
6.780
+0.240
(+3.67%)
Range
- - 6.800
(-%)
Open
-
Previous Close
6.540
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
65,081
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis